Skip to main content
Erschienen in: Clinical Rheumatology 1/2021

05.06.2020 | Original Article

Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study

verfasst von: Veli Yazisiz, Bengisu Aslan, Funda Erbasan, İsmail Uçar, Tahir Saygin Öğüt, Mustafa Ender Terzioğlu

Erschienen in: Clinical Rheumatology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study compared the clinical and serological characteristics of seronegative and seropositive primary Sjögren syndrome (pSS) and examined whether current classification criteria for pSS cover seronegative pSS.

Methods

The study group comprised 375 patients (341 women and 34 men) diagnosed with pSS. A clinical diagnosis by an expert rheumatologist was considered the “gold standard” for the diagnosis of pSS. The clinical and serological characteristics of the patients were retrospectively collected from hospital medical files.

Results

Fifty-eight of the 375 pSS patients (15.5%) were seronegative for ANA, RF, anti-Ro, and anti-La autoantibodies. Seronegative pSS was diagnosed based on lymphocytic infiltrations in lip biopsy samples. There were no statistically significant differences in terms of patient age, age at diagnosis, sex distribution, clinical features, and laboratory findings between seronegative and seropositive pSS. The frequency of hypergammaglobulinemia was higher in seropositive pSS. The 2016 ACR/ULAR criteria best covered most seronegative pSS cases (84.5%). For seronegative pSS, the agreement between the 2002 AECG, 2012 ACR, and 2016 ACR/EULAR criteria was relatively low.

Conclusions

The clinical features of seronegative pSS (i.e., a lack of four autoantibodies in serum) were similar to those of seropositive pSS. The current classification criteria for pSS should not be used in the diagnosis of seronegative pSS, as the agreement between the different sets of criteria was low, and some patients fell outside the classification. Further clinical and laboratory studies are needed to identify the features that distinguish seronegative pSS.
Key Points
• Approximately 15% of the pSS patients were seronegative for ANA, RF, anti-Ro, and anti-La autoantibodies.
• Seronegative pSS was diagnosed based on lymphocytic infiltrations in lip biopsy samples.
• The clinical features of seronegative pSS were similar to those of seropositive pSS.
• The current classification criteria for pSS should not be used in the diagnosis of seronegative patients, as the agreement between the different sets of criteria was low, and some patients fell outside the classification.
Literatur
10.
Zurück zum Zitat Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, Alunno A, Colafrancesco S, Luciano N, Giacomelli R, Gerli R, Valesini G, Bombardieri S, de Vita S (2015) Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev 14(11):1019–1022. https://doi.org/10.1016/j.autrev.2015.07.002CrossRefPubMed Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, Alunno A, Colafrancesco S, Luciano N, Giacomelli R, Gerli R, Valesini G, Bombardieri S, de Vita S (2015) Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev 14(11):1019–1022. https://​doi.​org/​10.​1016/​j.​autrev.​2015.​07.​002CrossRefPubMed
11.
Zurück zum Zitat Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM (2013) Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: a comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res (Hoboken) 65(8):1291–1298. https://doi.org/10.1002/acr.21956CrossRef Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM (2013) Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: a comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res (Hoboken) 65(8):1291–1298. https://​doi.​org/​10.​1002/​acr.​21956CrossRef
12.
Zurück zum Zitat Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Sjögren Big Data Consortium et al (2018) How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol 36 Suppl 112(3):102–112 Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Sjögren Big Data Consortium et al (2018) How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol 36 Suppl 112(3):102–112
13.
Zurück zum Zitat Brito-Zerón P, Retamozo S, Ramos-Casals M (2018) Phenotyping Sjögren’s syndrome: towards a personalised management of the disease. Clin Exp Rheumatol 36 Suppl 112(3):198–209 Brito-Zerón P, Retamozo S, Ramos-Casals M (2018) Phenotyping Sjögren’s syndrome: towards a personalised management of the disease. Clin Exp Rheumatol 36 Suppl 112(3):198–209
15.
Zurück zum Zitat Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups (2012) American College of Rheumatology Classification Criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the SICCA cohort. Arthritis Care Res (Hoboken) 64:475–487. https://doi.org/10.1002/acr.21591CrossRef Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups (2012) American College of Rheumatology Classification Criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the SICCA cohort. Arthritis Care Res (Hoboken) 64:475–487. https://​doi.​org/​10.​1002/​acr.​21591CrossRef
16.
Zurück zum Zitat Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9–16. https://doi.org/10.1136/annrheumdis-2016-210571CrossRefPubMed Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9–16. https://​doi.​org/​10.​1136/​annrheumdis-2016-210571CrossRefPubMed
17.
Zurück zum Zitat Tezcan ME, Kucuk H, Goker B (2017) American College of Rheumatology/European League Against Rheumatism Sjögren’s syndrome classification criteria may not be adequate for extraglandular disease and necessitate defining “seronegative Sjögren’s syndrome”: comment on the article by Shiboski et al. Arthritis Rheumatol 69(6):1341–1342. https://doi.org/10.1002/art.40083CrossRefPubMed Tezcan ME, Kucuk H, Goker B (2017) American College of Rheumatology/European League Against Rheumatism Sjögren’s syndrome classification criteria may not be adequate for extraglandular disease and necessitate defining “seronegative Sjögren’s syndrome”: comment on the article by Shiboski et al. Arthritis Rheumatol 69(6):1341–1342. https://​doi.​org/​10.​1002/​art.​40083CrossRefPubMed
18.
Zurück zum Zitat Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Sjögren’s International Collaborative Clinical Alliance Research Groups et al (2011) Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome among 1,726 registry participants. Arthritis Rheum 63(7):2021–2030. https://doi.org/10.1002/art.30381CrossRefPubMedPubMedCentral Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Sjögren’s International Collaborative Clinical Alliance Research Groups et al (2011) Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome among 1,726 registry participants. Arthritis Rheum 63(7):2021–2030. https://​doi.​org/​10.​1002/​art.​30381CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara N, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance Research Groups (2009) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 149(3):405–415. https://doi.org/10.1016/j.ajo.2009.09.013CrossRefPubMedPubMedCentral Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara N, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance Research Groups (2009) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 149(3):405–415. https://​doi.​org/​10.​1016/​j.​ajo.​2009.​09.​013CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, Sjögren’s Task Force EULAR (2010) EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 69(6):1103–1109. https://doi.org/10.1136/ard.2009.110619CrossRefPubMed Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, Sjögren’s Task Force EULAR (2010) EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 69(6):1103–1109. https://​doi.​org/​10.​1136/​ard.​2009.​110619CrossRefPubMed
25.
Zurück zum Zitat Park Y, Lee J, Koh JH, Sung YK, Lee SS, Choe JY et al (2019) Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren’s syndrome: data from a nationwide cohort for Sjögren’s syndrome in Korea. Clin Exp Rheumatol 37 Suppl 118(3):107–113PubMed Park Y, Lee J, Koh JH, Sung YK, Lee SS, Choe JY et al (2019) Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren’s syndrome: data from a nationwide cohort for Sjögren’s syndrome in Korea. Clin Exp Rheumatol 37 Suppl 118(3):107–113PubMed
26.
Zurück zum Zitat ter Borg EJ, Kelder JC (2014) Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren’s syndrome and widespread pain: evidence for a relatively benign subset. Clin Exp Rheumatol 32(3):349–353PubMed ter Borg EJ, Kelder JC (2014) Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren’s syndrome and widespread pain: evidence for a relatively benign subset. Clin Exp Rheumatol 32(3):349–353PubMed
32.
Zurück zum Zitat Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Noma H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T (2017) Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren’s syndrome with other sets of criteria in Japanese patients. Ann Rheum Dis 76(12):1980–1985. https://doi.org/10.1136/annrheumdis-2016-210758CrossRefPubMedPubMedCentral Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Noma H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T (2017) Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren’s syndrome with other sets of criteria in Japanese patients. Ann Rheum Dis 76(12):1980–1985. https://​doi.​org/​10.​1136/​annrheumdis-2016-210758CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat van Nimwegen JF, van Ginkel MS, Arends S, Haacke EA, van der Vegt B, Sillevis Smitt-Kamminga N, Spijkervet FKL, Kroese FGM, Stel AJ, Brouwer E, Vissink A, Bootsma H (2018) Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort. Rheumatology (Oxford) 57(5):818–825. https://doi.org/10.1093/rheumatology/kex495CrossRef van Nimwegen JF, van Ginkel MS, Arends S, Haacke EA, van der Vegt B, Sillevis Smitt-Kamminga N, Spijkervet FKL, Kroese FGM, Stel AJ, Brouwer E, Vissink A, Bootsma H (2018) Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort. Rheumatology (Oxford) 57(5):818–825. https://​doi.​org/​10.​1093/​rheumatology/​kex495CrossRef
Metadaten
Titel
Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study
verfasst von
Veli Yazisiz
Bengisu Aslan
Funda Erbasan
İsmail Uçar
Tahir Saygin Öğüt
Mustafa Ender Terzioğlu
Publikationsdatum
05.06.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 1/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05154-9

Weitere Artikel der Ausgabe 1/2021

Clinical Rheumatology 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.